NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

CompletedPhase 2

Sponsor: University of Colorado, Denver

Conditions: Breast Cancer Female

Interventions: Presentation of a personal breast cancer risk estimate

Countries: United States

The Understanding and Addressing Rejection of Personalized Cancer Risk Information study is a longitudinal study conducted to understand the nature of phenomenon of personalized cancer risk rejection in the context of mammography screening.

Eligibility overview

Sex: FEMALE

Age: 39 Years to 74 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

1. Female sex
2. Age 39-74 (i.e., people who are eligible for routine breast cancer screening and for whom guidelines recommend an informed, risk-based decision)
3. English literacy
4. Black or African American race

Exclusion Criteria:

1\. Prior diagnosis of

1. breast cancer
2. Ductal carcinoma in situ (DCIS)
3. Lobular carcinoma in situ (LCIS)
4. Known BRCA1/2 gene mutation
5. Cowan syndrome
6. Li-Fraumeni syndrome
7. Having received previous chest radiation for treatment of Hodgkin's lymphoma.

Locations (1)

Aurora, Colorado, United States